Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept + methotrexate withdrawal vs continuation in RA LDA maintenance
CTR20132939Phase 4Completed
- Sponsor
- Pfizer
- Start
- Apr 2015
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Started Apr 2015; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20132939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132939.